Correlation Between Takeda Pharmaceutical and Cannabis Suisse
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Cannabis Suisse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Cannabis Suisse into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Cannabis Suisse Corp, you can compare the effects of market volatilities on Takeda Pharmaceutical and Cannabis Suisse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Cannabis Suisse. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Cannabis Suisse.
Diversification Opportunities for Takeda Pharmaceutical and Cannabis Suisse
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Takeda and Cannabis is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Cannabis Suisse Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Suisse Corp and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Cannabis Suisse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Suisse Corp has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Cannabis Suisse go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Cannabis Suisse
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the Cannabis Suisse. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 66.7 times less risky than Cannabis Suisse. The stock trades about -0.04 of its potential returns per unit of risk. The Cannabis Suisse Corp is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 2.70 in Cannabis Suisse Corp on October 20, 2024 and sell it today you would lose (0.28) from holding Cannabis Suisse Corp or give up 10.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Takeda Pharmaceutical Co vs. Cannabis Suisse Corp
Performance |
| Timeline |
| Takeda Pharmaceutical |
| Cannabis Suisse Corp |
Takeda Pharmaceutical and Cannabis Suisse Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Takeda Pharmaceutical and Cannabis Suisse
The main advantage of trading using opposite Takeda Pharmaceutical and Cannabis Suisse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Cannabis Suisse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Suisse will offset losses from the drop in Cannabis Suisse's long position.| Takeda Pharmaceutical vs. Viatris | Takeda Pharmaceutical vs. Elanco Animal Health | Takeda Pharmaceutical vs. Zoetis Inc | Takeda Pharmaceutical vs. Emergent Biosolutions |
| Cannabis Suisse vs. Greater Cannabis | Cannabis Suisse vs. Global Hemp Group | Cannabis Suisse vs. Maple Leaf Green | Cannabis Suisse vs. Mc Endvrs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |